Screening for Psychiatric Morbidity in the Population - a Comparison of the GHQ-12 and Self-reported Medication Use

Overview

Journal Int J Popul Data Sci

Specialty Public Health

Date 2020 Sep 16

PMID 32934999

Citations 5

Authors

Foteini Tseliou

Michael Donnelly

Dermot OReilly

Affiliations

Soon will be listed here.

Abstract

Introduction: Uptake of psychotropic medication has been previously used as a proxy for assessing the prevalence of population mental health morbidity. However, it is not known how this compares with estimates derived from population screening tools.

Objective: To compare estimates of psychiatric morbidity derived by a validated screening instrument of psychiatric morbidity and a self-reported medication uptake measure.

Methods: This study used data from two recent population-wide health surveys in Northern Ireland, a country (UK) with free health services and no prescription charges. The psychiatric morbidity of 7,489 respondents was assessed using the GHQ-12 and self-reported use of medication for stress, anxiety and depression (sDAS medication).

Results: Overall, 19% of respondents were defined as 'cases' and 14.3% were taking sDAS medication. Generally, the two methods identified the same population distributions of characteristics that were associated with psychiatric morbidity though nearly as many non-cases as cases received sDAS medication (46.4% vs. 53.6%). A greater proportion of women and older people were identified as cases according to sDAS medication use, while no such variation was observed between socio-economic status and method of assessment.

Conclusions: This study indicates that these two methods of assessing population psychiatric morbidity provide similar estimates, despite potentially identifying different individuals as cases. It is important to note that different health care systems might be linked to variations in obstacles when accessing and using health care services.

Highlights: There was a reasonable correspondence between the different methods of assessment.A greater proportion of women and older people were identified as cases through the self-reported use of medication.An almost equal amount of GHQ-12 cases and non-cases reported being in receipt of medication.

Citing Articles

Dispensing patterns of antidepressant and antianxiety medications for psychiatric disorders after benign hysterectomy in reproductive-age women: Results from group-based trajectory modeling.

Ishiwata R, AlAshqar A, Miyashita-Ishiwata M, Borahay M Womens Health (Lond). 2024; 20:17455057241272218.

PMID: 39165003 PMC: 11339748. DOI: 10.1177/17455057241272218.

Longitudinal and Gender Measurement Invariance of the General Health Questionnaire-12 (GHQ-12) From Adolescence to Emerging Adulthood.

Schlechter P, Neufeld S Assessment. 2024; 31(8):1687-1701.

PMID: 38347744 PMC: 11492552. DOI: 10.1177/10731911241229573.

Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.

Polick C, Ploutz-Snyder R, Braley T, Connell C, Stoddard S PLoS One. 2023; 18(10):e0292233.

PMID: 37851620 PMC: 10584096. DOI: 10.1371/journal.pone.0292233.

The association between self-reported mental health, medication record and suicide risk: A population wide study.

Onyeka I, OReilly D, Maguire A SSM Popul Health. 2021; 13:100749.

PMID: 33665331 PMC: 7901032. DOI: 10.1016/j.ssmph.2021.100749.

The Dimensionality of the 12-Item General Health Questionnaire (GHQ-12): Comparisons of Factor Structures and Invariance Across Samples and Time.

Hystad S, Johnsen B Front Psychol. 2020; 11:1300.

PMID: 32595570 PMC: 7300277. DOI: 10.3389/fpsyg.2020.01300.

References

Fleury M, Ngamini Ngui A, Bamvita J, Grenier G, Caron J . Predictors of healthcare service utilization for mental health reasons. Int J Environ Res Public Health. 2014; 11(10):10559-86. PMC: 4210995. DOI: 10.3390/ijerph111010559. View

Jenkins R, Lewis G, Bebbington P, Brugha T, Farrell M, Gill B . The National Psychiatric Morbidity surveys of Great Britain--initial findings from the household survey. Psychol Med. 1997; 27(4):775-89. DOI: 10.1017/s0033291797005308. View

Mindell J, Biddulph J, Hirani V, Stamatakis E, Craig R, Nunn S . Cohort profile: the health survey for England. Int J Epidemiol. 2012; 41(6):1585-93. DOI: 10.1093/ije/dyr199. View

Olesen K, Rod N, Madsen I, Bonde J, Rugulies R . Does retirement reduce the risk of mental disorders? A national registry-linkage study of treatment for mental disorders before and after retirement of 245,082 Danish residents. Occup Environ Med. 2015; 72(5):366-72. PMC: 4413684. DOI: 10.1136/oemed-2014-102228. View

Magnusson Hanson L, Westerlund H, Chungkham H, Vahtera J, Sverke M, Alexanderson K . Purchases of Prescription Antidepressants in the Swedish Population in Relation to Major Workplace Downsizing. Epidemiology. 2015; 27(2):257-64. DOI: 10.1097/EDE.0000000000000414. View

Eaker S, Bergstrom R, Bergstrom A, Adami H, Nyren O . Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol. 1998; 147(1):74-82. DOI: 10.1093/oxfordjournals.aje.a009370. View

Lindblad F, Ringback Weitoft G, Hjern A . Maternal and paternal psychopathology increases risk of offspring ADHD equally. Epidemiol Psychiatr Sci. 2011; 20(4):367-72. DOI: 10.1017/s2045796011000564. View

Goldberg D, Gater R, Sartorius N, Ustun T, Piccinelli M, Gureje O . The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997; 27(1):191-7. DOI: 10.1017/s0033291796004242. View

Kessler R, Berglund P, Chiu W, Demler O, Heeringa S, Hiripi E . The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res. 2004; 13(2):69-92. PMC: 6878537. DOI: 10.1002/mpr.167. View

10.

Bennett K, Teeling M, Feely J . Overprescribing antidepressants to children: pharmacoepidemiological study in primary care. BMJ. 2005; 331(7530):1451-2. PMC: 1315653. DOI: 10.1136/bmj.331.7530.1451. View

11.

Hirvikoski T, Mittendorfer-Rutz E, Boman M, Larsson H, Lichtenstein P, Bolte S . Premature mortality in autism spectrum disorder. Br J Psychiatry. 2015; 208(3):232-8. DOI: 10.1192/bjp.bp.114.160192. View

12.

Shahar E, Folsom A, Jackson R . The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol. 1996; 6(6):498-506. DOI: 10.1016/s1047-2797(96)00104-4. View

13.

Crump C, Sundquist K, Sundquist J, Winkleby M . Neighborhood deprivation and psychiatric medication prescription: a Swedish national multilevel study. Ann Epidemiol. 2011; 21(4):231-7. PMC: 3541429. DOI: 10.1016/j.annepidem.2011.01.005. View

14.

Ekblad M, Gissler M, Lehtonen L, Korkeila J . Relation of prenatal smoking exposure and use of psychotropic medication up to young adulthood. Am J Epidemiol. 2011; 174(6):681-90. DOI: 10.1093/aje/kwr150. View

15.

. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(9995):743-800. PMC: 4561509. DOI: 10.1016/S0140-6736(15)60692-4. View

16.

Aalto A, Elovainio M, Kivimaki M, Uutela A, Pirkola S . The Beck Depression Inventory and General Health Questionnaire as measures of depression in the general population: a validation study using the Composite International Diagnostic Interview as the gold standard. Psychiatry Res. 2012; 197(1-2):163-71. DOI: 10.1016/j.psychres.2011.09.008. View

17.

Gardarsdottir H, Egberts A, van Dijk L, Sturkenboom M, Heerdink E . An algorithm to identify antidepressant users with a diagnosis of depression from prescription data. Pharmacoepidemiol Drug Saf. 2008; 18(1):7-15. DOI: 10.1002/pds.1677. View

18.

Mullan E, Katona P, DAth P, Katona C . Screening, detection and management of depression in elderly primary care attenders. II: Detection and fitness for treatment: a case record study. Fam Pract. 1994; 11(3):267-70. DOI: 10.1093/fampra/11.3.267. View

19.

Bulloch A, Patten S . Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol. 2009; 45(1):47-56. DOI: 10.1007/s00127-009-0041-5. View

20.

Lewis G, Pelosi A, Araya R, Dunn G . Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med. 1992; 22(2):465-86. DOI: 10.1017/s0033291700030415. View